IDO2 and cancer: The enzyme indoleamine 2,3-dioxygenase (IDO), which catalyzes the essential amino acid tryptophan along the kynurenine pathway, is widely expressed in human cancers, and higher IDO expression is correlated with poorer prognosis in a variety of cancer types (10).